David Richards

Chief Executive Officer

David Richards is an operational life sciences executive with expertise in corporate development, operations, capital structuring, research and development, program management, and intellectual property development. Prior to Clarametyx, Mr. Richards served in operational and general counsel roles for Aclipse Therapeutics, which develops novel inhibitors in the neurocognitive space; N8 Medical, Inc., which is commercializing novel small molecule compounds that mimic naturally occurring antimicrobial peptides; and PriorAuthNow, Inc., an emerging electronic prior authorization solutions provider. Prior to these roles, Mr. Richards served in operational and legal capacities for family office funds and was an associate at a large multinational law firm. Mr. Richards received a bachelor’s degree in economics from Vanderbilt University and his JD from the University of Texas.